Nuclear receptors and the control of metabolism.
暂无分享,去创建一个
Johan Auwerx | G. Francis | J. Auwerx | E. Fayard | F. Picard | Frédéric Picard | Gordon A Francis | Elisabeth Fayard | Elisabeth Fayard
[1] Jiong Zhou,et al. Liver Receptor Homologue-1 (LRH-1) Regulates Expression of Aromatase in Preadipocytes* , 2002, The Journal of Biological Chemistry.
[2] J. Huss,et al. PPAR signaling in the control of cardiac energy metabolism. , 2000, Trends in cardiovascular medicine.
[3] R. Evans,et al. A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis , 2001 .
[4] D W Nebert,et al. Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. , 1991, Molecular endocrinology.
[5] H. Brewer,et al. Tangier disease : A structural defect in apolipoprotein A-I ( apoA-ITangir ) ( apolipoprotein A-1 H / dyslipoproteinemia / atherosclerosis / high density lipoproteins / cholesterol ) , 2003 .
[6] J. Auwerx,et al. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[7] E. Ferrannini,et al. Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non‐insulin‐dependent diabetes , 1997, Clinical pharmacology and therapeutics.
[8] Johan Auwerx,et al. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity , 1998, Nature Genetics.
[9] J. Paré,et al. The Mouse Fetoprotein Transcription Factor (FTF) Gene Promoter Is Regulated by Three GATA Elements with Tandem E Box and Nkx Motifs, and FTF in Turn Activates the Hnf3β, Hnf4α, and Hnf1α Gene Promoters* , 2001, The Journal of Biological Chemistry.
[10] I. Phillips,et al. Orphan Receptor Promiscuity in the Induction of Cytochromes P450 by Xenobiotics* , 2001, The Journal of Biological Chemistry.
[11] J. Chiang,et al. Transcriptional Regulation of the Human Sterol 12α-Hydroxylase Gene (CYP8B1) , 2001, The Journal of Biological Chemistry.
[12] T. Funahashi,et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. , 2001, Diabetes.
[13] J. Auwerx,et al. PPAR gamma: an essential role in metabolic control. , 2001, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[14] T. Saruta,et al. Troglitazone ameliorates lipotoxicity in the beta cell line INS-1 expressing PPAR gamma. , 2002, Diabetes research and clinical practice.
[15] S. Gogg,et al. Thiazolidinediones (PPARγ agonists) but not PPAR α agonists increase IRS‐2 gene expression in 3T3‐L1 and human adipocytes 1 , 2001 .
[16] G. Ailhaud,et al. Cloning of a Protein That Mediates Transcriptional Effects of Fatty Acids in Preadipocytes , 1995, The Journal of Biological Chemistry.
[17] J. Auwerx,et al. Peroxisome proliferator-activated receptors, orphans with ligands and functions. , 1997, Current opinion in lipidology.
[18] T. Saruta,et al. Effects of troglitazone on fat distribution in the treatment of male type 2 diabetes. , 1999, Metabolism: clinical and experimental.
[19] E. Ernst,et al. Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.) , 1998, European Journal of Clinical Pharmacology.
[20] M. Pfahl,et al. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily , 1994, Molecular and cellular biology.
[21] J. Halpert,et al. cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450. , 2001, Molecular pharmacology.
[22] J. Bilakovics,et al. A Selective Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Modulator Blocks Adipocyte Differentiation but Stimulates Glucose Uptake in 3T3-L1 Adipocytes , 2000 .
[23] J. Auwerx,et al. The small heterodimer partner interacts with the liver X receptor alpha and represses its transcriptional activity. , 2002, Molecular endocrinology.
[24] B. Spiegelman,et al. 15-Deoxy-Δ 12,14-Prostaglandin J 2 is a ligand for the adipocyte determination factor PPARγ , 1995, Cell.
[25] David M. Heery,et al. A signature motif in transcriptional co-activators mediates binding to nuclear receptors , 1997, Nature.
[26] J. Auwerx,et al. Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes. , 1999, Biochemical and biophysical research communications.
[27] D. Moore,et al. An Orphan Nuclear Hormone Receptor That Lacks a DNA Binding Domain and Heterodimerizes with Other Receptors , 1996, Science.
[28] F. Gonzalez,et al. Human cytochromes P450: problems and prospects. , 1992, Trends in pharmacological sciences.
[29] G. Gil,et al. Suppression of sterol 12alpha-hydroxylase transcription by the short heterodimer partner: insights into the repression mechanism. , 2001, Nucleic acids research.
[30] P. Puigserver,et al. Transcriptional regulation of adipogenesis. , 2000, Genes & development.
[31] H. Selye. Hormones and resistance. , 1970, Journal of pharmaceutical sciences.
[32] M. Belury,et al. Conjugated linoleic acid activates peroxisome proliferator-activated receptor α and β subtypes but does not induce hepatic peroxisome proliferation in Sprague–Dawley rats , 1999 .
[33] D. Schrenk,et al. Up-regulation of transporters of the MRP family by drugs and toxins. , 2001, Toxicology letters.
[34] J. Berger,et al. Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes. , 1994, The Journal of biological chemistry.
[35] L. Moore,et al. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[36] M. Byrne,et al. Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance. , 1997, The Journal of clinical investigation.
[37] R. Krauss,et al. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI , 1991, Nature.
[38] R. Walczak,et al. Autoregulation of the Human Liver X Receptor α Promoter , 2001, Molecular and Cellular Biology.
[39] M. Lazar,et al. A Potent Antidiabetic Thiazolidinedione with Unique Peroxisome Proliferator-activated Receptor γ-activating Properties* , 1998, The Journal of Biological Chemistry.
[40] N. Shachter. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism , 2001, Current opinion in lipidology.
[41] P. Denéfle,et al. Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits. , 1996, Circulation.
[42] J. Auwerx,et al. Tissue Distribution and Quantification of the Expression of mRNAs of Peroxisome Proliferator–Activated Receptors and Liver X Receptor-α in Humans: No Alteration in Adipose Tissue of Obese and NIDDM Patients , 1997, Diabetes.
[43] A. Tall,et al. The Orphan Nuclear Receptor LRH-1 Potentiates the Sterol-mediated Induction of the Human CETP Gene by Liver X Receptor* 210 , 2001, The Journal of Biological Chemistry.
[44] J. Lehmann,et al. N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents. , 1998, Journal of medicinal chemistry.
[45] M. Lazar,et al. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Auwerx,et al. Coordinate Regulation of the Expression of the Fatty Acid Transport Protein and Acyl-CoA Synthetase Genes by PPARα and PPARγ Activators* , 1997, The Journal of Biological Chemistry.
[47] H. Brewer,et al. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[48] U. Francke,et al. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. , 1991, The Journal of biological chemistry.
[49] J. Breslow,et al. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[50] R Ohlsson,et al. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[51] R. Carroll,et al. Peroxisome proliferator-activated receptor-α ligands inhibit cardiac lipoprotein lipase activity , 2001 .
[52] Eric S. Lander,et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes , 2000, Nature Genetics.
[53] T. Willson,et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ , 1998, Nature.
[54] R. Hiipakka,et al. Ubiquitous receptor: a receptor that modulates gene activation by retinoic acid and thyroid hormone receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[55] W. Koenig,et al. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators , 1998, Nature.
[56] Christopher K. Glass,et al. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function , 1997, Nature.
[57] R. Evans,et al. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[58] Yanhong Shi,et al. The peroxisome proliferator-activated receptor δ, an integrator of transcriptional repression and nuclear receptor signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[59] J. Thorp,et al. Modification of Metabolism and Distribution of Lipids by Ethyl Chlorophenoxyisobutyrate , 1962, Nature.
[60] J. Berger,et al. Differential Gene Regulation in Human Versus Rodent Hepatocytes by Peroxisome Proliferator-activated Receptor (PPAR) α , 2001, The Journal of Biological Chemistry.
[61] K. Umesono,et al. LXR, a nuclear receptor that defines a distinct retinoid response pathway. , 1995, Genes & development.
[62] W. Wahli,et al. Printed in U.S.A. Copyright © 2001 by The Endocrine Society Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding , 2022 .
[63] M. Olive,et al. Life without white fat: a transgenic mouse. , 1998, Genes & development.
[64] D. Gordon,et al. Rationale and design of the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol. , 1993, The American journal of cardiology.
[65] J. Lehmann,et al. A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[66] P. Meier,et al. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[67] H. Kolb,et al. Systemic Bias of Cytokine Production Toward Cell-Mediated Immune Regulation in IDDM and Toward Humoral Immunity in Graves' Disease , 1997, Diabetes.
[68] G. Shulman,et al. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. , 1998, The New England journal of medicine.
[69] S. Yokoyama,et al. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. , 1996, Journal of lipid research.
[70] D. Moore,et al. Novel receptor interaction and repression domains in the orphan receptor SHP , 1997, Molecular and cellular biology.
[71] T. A. Kerr,et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. , 2000, Molecular cell.
[72] S. Mudaliar,et al. Peroxisome Proliferator-Activated Receptor (PPAR) γ and Retinoid X Receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle , 2001, Diabetologia.
[73] Christine Dreyer,et al. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors , 1992, Cell.
[74] J Auwerx,et al. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. , 1996, Biochimica et biophysica acta.
[75] C. Glass,et al. Conditional Disruption of the Peroxisome Proliferator-Activated Receptor γ Gene in Mice Results in Lowered Expression of ABCA1, ABCG1, and apoE in Macrophages and Reduced Cholesterol Efflux , 2002, Molecular and Cellular Biology.
[76] A. Vaughan,et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. , 1999, The Journal of clinical investigation.
[77] D. Mangelsdorf,et al. Regulated Expression of the Apolipoprotein E/C-I/C-IV/C-II Gene Cluster in Murine and Human Macrophages , 2002, The Journal of Biological Chemistry.
[78] K. Umesono,et al. A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice. , 2000, Diabetes.
[79] S. Sutou,et al. Molecular cloning of chicken FTZ-F1-related orphan receptors. , 1997, Gene.
[80] G. Cooney,et al. Peroxisome Proliferator—Activated Receptor (PPAR)-α Activation Lowers Muscle Lipids and Improves Insulin Sensitivity in High Fat—Fed Rats Comparison With PPAR-γ Activation , 2001 .
[81] Y. Iwamoto,et al. Enhanced Expression of the Human Multidrug Resistance Protein 3 by Bile Salt in Human Enterocytes , 2001, The Journal of Biological Chemistry.
[82] K. Umesono,et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. , 1998, The Journal of clinical investigation.
[83] R. Costa,et al. The nuclear receptor fetoprotein transcription factor is coexpressed with its target gene HNF-3β in the developing murine liver intestine and pancreas , 1999, Mechanisms of Development.
[84] J. Paré,et al. The alpha1-fetoprotein locus is activated by a nuclear receptor of the Drosophila FTZ-F1 family , 1996, Molecular and cellular biology.
[85] T. Tai,et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. , 2001, The Journal of clinical endocrinology and metabolism.
[86] D. Mangelsdorf,et al. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[87] D. Moore,et al. , Margarita for Repression MechanismsReceptor Transactivation : Two XHepatocyte Nuclear Factor 4 and Retinoid The Orphan Nuclear Receptor SHP Inhibits , 1999 .
[88] J. Auwerx,et al. Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes. , 1999, Diabetes.
[89] J. Auwerx,et al. PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter , 1998 .
[90] S. Yeh,et al. Identification of ARA70 as a Ligand-enhanced Coactivator for the Peroxisome Proliferator-activated Receptor γ* , 1999, The Journal of Biological Chemistry.
[91] P. Edwards,et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[92] Daniel Metzger,et al. Impaired skin wound healing in peroxisome proliferator–activated receptor (PPAR)α and PPARβ mutant mice , 2001, The Journal of cell biology.
[93] Jasmine Chen,et al. Identification of a nuclear receptor that is activated by farnesol metabolites , 1995, Cell.
[94] K. Heidenreich,et al. In vitro studies on the action of CS-045, a new antidiabetic agent. , 1990, Metabolism: clinical and experimental.
[95] T. Leff,et al. Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action. , 1995, Journal of lipid research.
[96] J. Chiang,et al. Nuclear receptor-mediated repression of human cholesterol 7alpha-hydroxylase gene transcription by bile acids. , 2001, Journal of lipid research.
[97] W. Wahli,et al. Critical roles of PPARβ/δ in keratinocyte response to inflammation , 2001 .
[98] M. Freeman,et al. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size. , 2000, Journal of lipid research.
[99] C. Sensen,et al. Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux , 1999, The Lancet.
[100] S. Kliewer,et al. A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[101] J. Auwerx,et al. Expression of peroxisome proliferator-activated receptor γ (PPARγ) in normal human pancreatic islet cells , 2000, Diabetologia.
[102] J. Thomsen,et al. The Orphan Nuclear Receptor SHP Inhibits Agonist-dependent Transcriptional Activity of Estrogen Receptors ERα and ERβ* , 1999, The Journal of Biological Chemistry.
[103] J. Auwerx,et al. The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene* , 1997, The Journal of Biological Chemistry.
[104] M. Moisan,et al. Characterization of the mouse FTZ-F1 gene, which encodes a key regulator of steroid hydroxylase gene expression. , 1993, Molecular endocrinology.
[105] R. Evans,et al. Pharmaceutical use of mouse models humanized for the xenobiotic receptor. , 2002, Drug discovery today.
[106] D. Mangelsdorf,et al. Orphan Nuclear Receptors as eLiXiRs and FiXeRs of Sterol Metabolism* , 2001, The Journal of Biological Chemistry.
[107] L. Madsen,et al. Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response. , 1999, Circulation.
[108] G. Gil,et al. Role of FXR and FTF in bile acid-mediated suppression of cholesterol 7alpha-hydroxylase transcription. , 2000, Nucleic acids research.
[109] W. Xie,et al. Orphan Nuclear Receptors: The Exotics of Xenobiotics* , 2001, The Journal of Biological Chemistry.
[110] J. Falloon,et al. Indinavir concentrations and St John's wort , 2000, The Lancet.
[111] Johan Auwerx,et al. Depot-Specific Differences in Adipose Tissue Gene Expression in Lean and Obese Subjects , 1998, Diabetes.
[112] T. Taniguchi,et al. Characterization of Hepatic-specific Regulatory Elements in the Promoter Region of the Human Cholesterol 7α-Hydroxylase Gene* , 1997, The Journal of Biological Chemistry.
[113] D. Moore,et al. Differential Transactivation by Two Isoforms of the Orphan Nuclear Hormone Receptor CAR* , 1997, The Journal of Biological Chemistry.
[114] Timothy M. Willson,et al. Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway* , 1997, The Journal of Biological Chemistry.
[115] G. Luc,et al. Induction of the Phospholipid Transfer Protein Gene Accounts for the High Density Lipoprotein Enlargement in Mice Treated with Fenofibrate* , 2001, The Journal of Biological Chemistry.
[116] H. Aburatani,et al. Genomic structure and mapping of human orphan receptor LXR alpha: upregulation of LXRa mRNA during monocyte to macrophage differentiation. , 2000, Journal of atherosclerosis and thrombosis.
[117] R. Hammer,et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. , 1998, Genes & development.
[118] T. Langmann,et al. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. , 1999, Biochemical and biophysical research communications.
[119] P. Bosma,et al. Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene , 1996, Science.
[120] I. Issemann,et al. The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. , 1993, Journal of molecular endocrinology.
[121] A. Tall,et al. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. , 1998, Annual review of nutrition.
[122] O. Mcbride,et al. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. , 1993, Biochemistry.
[123] R. Evans,et al. Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.
[124] L. Moore,et al. Orphan Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Share Xenobiotic and Steroid Ligands* , 2000, The Journal of Biological Chemistry.
[125] K. Silver,et al. Molecular Scanning of the Human Peroxisome Proliferator Activated Receptor γ (hPPARγ) Gene in Diabetic Caucasians: Identification of a Pro12Ala PPARγ2 Missense Mutation , 1997 .
[126] B. M. Forman,et al. Peptide Mimetic HIV Protease Inhibitors Are Ligands for the Orphan Receptor SXR* , 2001, The Journal of Biological Chemistry.
[127] M. Dong,et al. Effects of pioglitazone on promoting energy storage, not expenditure, in brown adipose tissue of obese fa/fa Zucker rats: comparison to CL 316,243. , 2000, Metabolism: clinical and experimental.
[128] B. Spiegelman,et al. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor , 1994, Cell.
[129] M. Kool,et al. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. , 1998, The Journal of clinical investigation.
[130] R. Burcelin,et al. Acute stimulation of glucose metabolism in mice by leptin treatment , 1997, Nature.
[131] Adriane Fugh-Berman,et al. Herb-drug interactions , 2000, The Lancet.
[132] A. Tall,et al. Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences. , 1992, The Journal of clinical investigation.
[133] P. Kushner,et al. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. , 1995, The EMBO journal.
[134] C. Sensen,et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.
[135] R. Eckel,et al. Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity. , 2001, Molecular pharmacology.
[136] W. Wahli,et al. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. , 1996, Endocrinology.
[137] D. Moore,et al. Dual Mechanisms for Repression of the Monomeric Orphan Receptor Liver Receptor Homologous Protein-1 by the Orphan Small Heterodimer Partner* , 2002, The Journal of Biological Chemistry.
[138] J. Gustafsson,et al. Synergistic activation of RLD-1 by agents triggering PKA and PKC dependent signalling. , 1998, Biochemical and biophysical research communications.
[139] M. Privalsky,et al. The SMRT corepressor is a target of phosphorylation by protein kinase CK2 (casein kinase II) , 2001, Molecular and Cellular Biochemistry.
[140] M. Matsuda,et al. Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone. , 2001, Diabetes care.
[141] Steven L. Cohen,et al. Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.
[142] M. Makishima,et al. Identification of a nuclear receptor for bile acids. , 1999, Science.
[143] G. Zhou,et al. Insulin- and Mitogen-activated Protein Kinase-mediated Phosphorylation and Activation of Peroxisome Proliferator-activated Receptor γ* , 1996, The Journal of Biological Chemistry.
[144] Paavo Honkakoski,et al. The Repressed Nuclear Receptor CAR Responds to Phenobarbital in Activating the Human CYP2B6 Gene* , 1999, The Journal of Biological Chemistry.
[145] B. Spiegelman,et al. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. , 1994, Genes & development.
[146] Oliver Burk,et al. Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin* , 2001, The Journal of Biological Chemistry.
[147] P. Meier,et al. Substrate specificity of the rat liver Na+-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[148] W. Wahli,et al. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. , 2000, Molecular endocrinology.
[149] A. Tall,et al. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. , 2000, The Journal of biological chemistry.
[150] A. Mahfoudi,et al. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[151] Masahiro Tohkin,et al. Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.
[152] J. Berger,et al. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. , 1995, Endocrinology.
[153] J. Capone,et al. The short heterodimer partner receptor differentially modulates peroxisome proliferator-activated receptor α-mediated transcription from the peroxisome proliferator-response elements of the genes encoding the peroxisomal β-oxidation enzymes acyl-CoA oxidase and hydratase-dehydrogenase , 2001, Molecular and Cellular Endocrinology.
[154] R. Evans,et al. Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency , 2000 .
[155] D. Mangelsdorf,et al. Human White/Murine ABC8 mRNA Levels Are Highly Induced in Lipid-loaded Macrophages , 2000, The Journal of Biological Chemistry.
[156] Gaochao Zhou,et al. 27-Hydroxycholesterol Is an Endogenous Ligand for Liver X Receptor in Cholesterol-loaded Cells* , 2001, The Journal of Biological Chemistry.
[157] P. Galtier,et al. Peroxisome Proliferator-activated Receptor α-Isoform Deficiency Leads to Progressive Dyslipidemia with Sexually Dimorphic Obesity and Steatosis* , 1998, The Journal of Biological Chemistry.
[158] R. Evans,et al. Nuclear receptors and lipid physiology: opening the X-files. , 2001, Science.
[159] J. Gustafsson,et al. Heterodimeric interaction between retinoid X receptor alpha and orphan nuclear receptor OR1 reveals dimerization-induced activation as a novel mechanism of nuclear receptor activation , 1997, Molecular and cellular biology.
[160] J. Lehmann,et al. An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway , 1998, Cell.
[161] K. Moulder,et al. Sulfated Glycans Stimulate Endocytosis of the Cellular Isoform of the Prion Protein, PrPC, in Cultured Cells (*) , 1995, The Journal of Biological Chemistry.
[162] B. Spiegelman,et al. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. , 1996, The Journal of clinical investigation.
[163] Reddy Jk,et al. Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans , 1983 .
[164] J. Auwerx,et al. Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor , 1996, Molecular and cellular biology.
[165] G. Lavorgna,et al. FTZ-F1, a steroid hormone receptor-like protein implicated in the activation of fushi tarazu , 1991, Science.
[166] H K Kroemer,et al. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. , 1999, The Journal of clinical investigation.
[167] J. Auwerx,et al. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. , 1996, The Journal of clinical investigation.
[168] A. Saltiel,et al. Cloning and Characterization of a Functional Peroxisome Proliferator Activator Receptor-γ-responsive Element in the Promoter of the CAP Gene* , 2000, The Journal of Biological Chemistry.
[169] M. Lazar,et al. Transcriptional Activation by Peroxisome Proliferator-activated Receptor γ Is Inhibited by Phosphorylation at a Consensus Mitogen-activated Protein Kinase Site* , 1997, The Journal of Biological Chemistry.
[170] G. Gil,et al. Alpha 1-fetoprotein transcription factor is required for the expression of sterol 12alpha -hydroxylase, the specific enzyme for cholic acid synthesis. Potential role in the bile acid-mediated regulation of gene transcription. , 2000, The Journal of biological chemistry.
[171] J. Auwerx,et al. A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. , 2001, Molecular cell.
[172] W. J. Johnson,et al. Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes. , 1998, Atherosclerosis.
[173] C. Chai,et al. Developmental expression of a novel Ftz-F1 homologue, ff1b (NR5A4), in the zebrafish Danio rerio , 2000, Mechanisms of Development.
[174] T. Langmann,et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease , 1999, Nature Genetics.
[175] R. Hammer,et al. Cholesterol and Bile Acid Metabolism Are Impaired in Mice Lacking the Nuclear Oxysterol Receptor LXRα , 1998, Cell.
[176] M. Lazar,et al. The hormone resistin links obesity to diabetes , 2001, Nature.
[177] S. Kliewer,et al. Use of the nuclear receptor PXR to predict drug interactions. , 2000, Toxicology.
[178] D. Moore,et al. Structure and Expression of the Orphan Nuclear ReceptorSHP Gene* , 1998, The Journal of Biological Chemistry.
[179] C. Dina,et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. , 2000, American journal of human genetics.
[180] J. Ward,et al. Growth, Adipose, Brain, and Skin Alterations Resulting from Targeted Disruption of the Mouse Peroxisome Proliferator-Activated Receptor β(δ) , 2000, Molecular and Cellular Biology.
[181] T. Willson,et al. Comprehensive Messenger Ribonucleic Acid Profiling Reveals That Peroxisome Proliferator-Activated Receptor γ Activation Has Coordinate Effects on Gene Expression in Multiple Insulin-Sensitive Tissues. , 2001, Endocrinology.
[182] J. Auwerx,et al. Cross-Talk between Fatty Acid and Cholesterol Metabolism Mediated by Liver X Receptor-α , 2000 .
[183] T. Fujiwara,et al. Troglitazone can prevent development of type 1 diabetes induced by multiple low-dose streptozotocin in mice. , 1999, Life sciences.
[184] R. Lawn,et al. ABCA1. The gatekeeper for eliminating excess tissue cholesterol. , 2001, Journal of lipid research.
[185] H. Jörnvall,et al. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. , 1989, The Journal of biological chemistry.
[186] Wei Chen,et al. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. , 2001, Diabetes.
[187] I. Björkhem,et al. Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid. , 1980, The Journal of clinical investigation.
[188] J Auwerx,et al. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. , 1996, Journal of lipid research.
[189] J. Chiang,et al. Identification of a bile acid response element in the cholesterol 7 alpha-hydroxylase gene CYP7A. , 1997, The American journal of physiology.
[190] Y. Ouchi,et al. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in rat aortic smooth muscle cells. , 1998, Biochemical and biophysical research communications.
[191] Yannick Hamon,et al. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. , 2000, Nature Cell Biology.
[192] T. Willson,et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[193] J. Chiang,et al. Regulation of cholesterol 7α-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRα) , 2001 .
[194] J. Morrow,et al. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. , 1999, Genes & development.
[195] D. Russell,et al. Disruption of the Sterol 27-Hydroxylase Gene in Mice Results in Hepatomegaly and Hypertriglyceridemia , 2000, The Journal of Biological Chemistry.
[196] V. Laudet,et al. The Nuclear Receptors Peroxisome Proliferator-activated Receptor α and Rev-erbα Mediate the Species-specific Regulation of Apolipoprotein A-I Expression by Fibrates* , 1998, The Journal of Biological Chemistry.
[197] J. Polonovski,et al. [Structure and metabolism of plasma lipoproteins]. , 1983, Pathologie-biologie.
[198] J. Krützfeldt,et al. Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells. , 2001, Biochemical and biophysical research communications.
[199] D. Mangelsdorf,et al. Regulation of Lipoprotein Lipase by the Oxysterol Receptors, LXRα and LXRβ* , 2001, The Journal of Biological Chemistry.
[200] L. Orci,et al. Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[201] S. Mudaliar,et al. Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action , 2000, Diabetologia.
[202] M. D. Leibowitz,et al. Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents. , 2001, Molecular pharmacology.
[203] J. Peters,et al. Mechanism of Action of the Nongenotoxic Peroxisome Proliferators: Role of the Peroxisome Proliferator-Activated Receptor α , 1998 .
[204] A. Tremblay,et al. Regional and gender variations in adipose tissue lipolysis in response to weight loss. , 1999, Journal of lipid research.
[205] W. Sabbagh,et al. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. , 1998, Genes & development.
[206] G. Renier,et al. Direct regulatory effect of fatty acids on macrophage lipoprotein lipase: potential role of PPARs. , 2001, Diabetes.
[207] L. Daviet,et al. LXRalpha functions as a cAMP-responsive transcriptional regulator of gene expression. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[208] T. Sasaoka,et al. Pioglitazone Ameliorates Tumor Necrosis Factor-α–Induced Insulin Resistance by a Mechanism Independent of Adipogenic Activity of Peroxisome Proliferator–Activated Receptor-γ , 2001 .
[209] R. Prough,et al. Regulation of the rat glutathione S-transferase A2 gene by glucocorticoids: involvement of both the glucocorticoid and pregnane X receptors. , 2001, Molecular pharmacology.
[210] B. Spiegelman,et al. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene , 1995, Molecular and cellular biology.
[211] J. van der Linden,et al. Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin. , 1999, Journal of lipid research.
[212] E. Ernst,et al. Second thoughts about safety of St John's wort , 1999, The Lancet.
[213] A. Horwitz,et al. Identification of cAMP analogue inducible genes in RAW264 macrophages. , 2000, Biochimica et biophysica acta.
[214] J. Cha,et al. Peroxisomal Proliferator-Activated Receptor-γ Upregulates Glucokinase Gene Expression in β-Cells , 2002 .
[215] J. Flier,et al. Ligand-independent Activation Domain in the N Terminus of Peroxisome Proliferator-activated Receptor γ (PPARγ) , 1997, The Journal of Biological Chemistry.
[216] A. Tall,et al. Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1* , 2000, The Journal of Biological Chemistry.
[217] M. Jimenez-Linan,et al. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. , 1997, The Journal of clinical investigation.
[218] J Auwerx,et al. Induction of the Acyl-Coenzyme A Synthetase Gene by Fibrates and Fatty Acids Is Mediated by a Peroxisome Proliferator Response Element in the C Promoter (*) , 1995, The Journal of Biological Chemistry.
[219] C. Fielding,et al. Molecular physiology of reverse cholesterol transport. , 1995, Journal of lipid research.
[220] H. Brewer,et al. Cellular localization and trafficking of the human ABCA1 transporter. , 2001 .
[221] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[222] R. Evans,et al. Orphan nuclear receptors--new ligands and new possibilities. , 1998, Genes & development.
[223] R. Peshock,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Adipose Tissue Distribution Pattern in Patients with , 2022 .
[224] B. O’Malley,et al. Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.
[225] J. Wilcox,et al. Localization of Human ATP-Binding Cassette Transporter 1 (ABC1) in Normal and Atherosclerotic Tissues , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[226] G. Francis,et al. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. , 1995, The Journal of clinical investigation.
[227] T. Hashimoto,et al. PEROXISOMAL β-OXIDATION AND PEROXISOME PROLIFERATOR–ACTIVATED RECEPTOR α: An Adaptive Metabolic System , 2001 .
[228] C. Thummel,et al. Potential role for a FTZ-F1 steroid receptor superfamily member in the control of Drosophila metamorphosis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[229] M. Denison,et al. Xenobiotic-inducible Transcription of Cytochrome P450 Genes (*) , 1995, The Journal of Biological Chemistry.
[230] R. Hammer,et al. Diminished Hepatic Response to Fasting/Refeeding and Liver X Receptor Agonists in Mice with Selective Deficiency of Sterol Regulatory Element-binding Protein-1c* , 2002, The Journal of Biological Chemistry.
[231] E. Kraegen,et al. A New Antidiabetic Agent, BRL 49653, Reduces Lipid Availability and Improves Insulin Action and Glucoregulation in the Rat , 1994, Diabetes.
[232] T. Tsukamoto,et al. An orphan nuclear receptor lacking a zinc-finger DNA-binding domain: interaction with several nuclear receptors. , 1997, Biochimica et biophysica acta.
[233] J Auwerx,et al. PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene. , 1996, The EMBO journal.
[234] T. Willson,et al. Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes , 2001, Genome Biology.
[235] W. Wahli,et al. Peroxisome proliferator-activated receptors: nuclear control of metabolism. , 1999, Endocrine reviews.
[236] L. Moore,et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.
[237] Bruce M. Spiegelman,et al. Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγ , 1996, Science.
[238] T. Buchanan,et al. Effect of Troglitazone on Insulin Sensitivity and Pancreatic β-Cell Function in Women at High Risk for NIDDM , 1996, Diabetes.
[239] M. McDonnell,et al. Cholesteryl ester transfer protein (CETP) mRNA abundance in human adipose tissue: relationship to cell size and membrane cholesterol content. , 1995, Journal of lipid research.
[240] Paul T Tarr,et al. Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor* , 2002, The Journal of Biological Chemistry.
[241] B. Spiegelman,et al. Analysis of a tissue-specific enhancer: ARF6 regulates adipogenic gene expression , 1992, Molecular and cellular biology.
[242] T. Langmann,et al. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice , 2000, Nature Genetics.
[243] Shutsung Liao,et al. Cholestenoic Acid Is a Naturally Occurring Ligand for Liver X Receptor α* * This work was supported by NIH grants. , 2000, Endocrinology.
[244] M. Yano,et al. Regulation of cytochrome P450 genes: molecular mechanisms. , 1993, Pharmacogenetics.
[245] E. Schuetz,et al. Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element. , 1998, Molecular pharmacology.
[246] W. J. Johnson,et al. Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. , 1992, Journal of lipid research.
[247] Masahisa Nakamura,et al. FTZ-F1α is expressed in the developing gonad of frogs , 2000 .
[248] Á. Pascual,et al. Nuclear hormone receptors and gene expression. , 2001, Physiological reviews.
[249] Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. , 1992, Molecular endocrinology.
[250] J. Auwerx,et al. Pioglitazone Induces In Vivo Adipocyte Differentiation in the Obese Zucker fa/fa Rat , 1997, Diabetes.
[251] J. Weber,et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[252] R. Drouin,et al. Assignment1 of the fetoprotein transcription factor gene (FTF) to human chromosome band 1q32.11 by in situ hybridization , 1998, Cytogenetic and Genome Research.
[253] D. Keppler,et al. cDNA Cloning of the Hepatocyte Canalicular Isoform of the Multidrug Resistance Protein, cMrp, Reveals a Novel Conjugate Export Pump Deficient in Hyperbilirubinemic Mutant Rats* , 1996, The Journal of Biological Chemistry.
[254] D. Moore,et al. Activation of the Promoter of the Orphan Receptor SHP by Orphan Receptors That Bind DNA as Monomers* , 1999, The Journal of Biological Chemistry.
[255] M. Cnop,et al. Troglitazone does not protect rat pancreatic beta cells against free fatty acid-induced cytotoxicity. , 2002, Biochemical pharmacology.
[256] T. Uchiumi,et al. Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2) , 1999, FEBS letters.
[257] Peter J. Brown,et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ , 1997 .
[258] J. Auwerx. PPARγ, the ultimate thrifty gene , 1999, Diabetologia.
[259] Jasmine Chen,et al. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.
[260] W. Rainey,et al. Liver receptor homologue-1 is expressed in the adrenal and can regulate transcription of 11 beta-hydroxylase. , 2001, Journal of molecular endocrinology.
[261] D. Moore,et al. The Farnesoid X-activated Receptor Mediates Bile Acid Activation of Phospholipid Transfer Protein Gene Expression* , 2000, The Journal of Biological Chemistry.
[262] D. Altshuler,et al. The role of PPAR-γ in macrophage differentiation and cholesterol uptake , 2001, Nature Medicine.
[263] C. S. Wang,et al. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. , 1985, The Journal of clinical investigation.
[264] Y. Sugiyama,et al. Transport of Drugs Across the Hepatic Sinusoidal Membrane: Sinusoidal Drug Influx and Efflux in the Liver , 2000, Seminars in liver disease.
[265] G. Francis,et al. Targeting HDL-mediated cellular cholesterol efflux for the treatment and prevention of atherosclerosis. , 1999, Clinica chimica acta; international journal of clinical chemistry.
[266] J. Auwerx,et al. Expression of the Peroxisome Proliferator-activated Receptor Gene Is Stimulated by Stress and Follows a Diurnal Rhythm (*) , 1996, The Journal of Biological Chemistry.
[267] T. Willson,et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[268] R. Lawn,et al. ABCA1 Is the cAMP-inducible Apolipoprotein Receptor That Mediates Cholesterol Secretion from Macrophages* , 2000, The Journal of Biological Chemistry.
[269] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[270] A. Tall. Plasma cholesteryl ester transfer protein. , 1993, Journal of lipid research.
[271] C. Glass,et al. A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression , 1997, nature.
[272] J. Lehmann,et al. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. , 1998, The Journal of clinical investigation.
[273] S. Kliewer,et al. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[274] J. Lehmann,et al. Activation of the orphan receptor RIP14 by retinoids. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[275] Peter Tontonoz,et al. Direct and Indirect Mechanisms for Regulation of Fatty Acid Synthase Gene Expression by Liver X Receptors* , 2002, The Journal of Biological Chemistry.
[276] Y. Matsuzawa,et al. Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[277] J. E. Silva,et al. Thiazolidinediones inhibit the expression of beta3-adrenergic receptors at a transcriptional level. , 2000, Diabetes.
[278] Suzhen Li,et al. Induction of Human Liver X Receptor α Gene Expression Via an Autoregulatory Loop Mechanism , 2002 .
[279] D. Russell,et al. Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. , 1991, The Journal of biological chemistry.
[280] D. Moller,et al. A Potent Synthetic LXR Agonist Is More Effective than Cholesterol Loading at Inducing ABCA1 mRNA and Stimulating Cholesterol Efflux* , 2002, The Journal of Biological Chemistry.
[281] B. Spiegelman,et al. A Synthetic Antagonist for the Peroxisome Proliferator-activated Receptor γ Inhibits Adipocyte Differentiation* , 2000, The Journal of Biological Chemistry.
[282] R. Unger,et al. Troglitazone Lowers Islet Fat and Restores Beta Cell Function of Zucker Diabetic Fatty Rats* , 1998, The Journal of Biological Chemistry.
[283] J. Pascussi,et al. Induction of CYP2C genes in human hepatocytes in primary culture. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[284] I. Issemann,et al. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators , 1990, Nature.
[285] B. Staels,et al. Activation of Proliferator-activated Receptors α and γ Induces Apoptosis of Human Monocyte-derived Macrophages* , 1998, The Journal of Biological Chemistry.
[286] A. Tall,et al. Scavenger Receptor-BI Inhibits ATP-binding Cassette Transporter 1- mediated Cholesterol Efflux in Macrophages* , 2000, The Journal of Biological Chemistry.
[287] V. Laudet,et al. How many nuclear hormone receptors are there in the human genome? , 2001, Trends in genetics : TIG.
[288] X. Chen,et al. Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[289] J. Lehmann,et al. An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*) , 1995, The Journal of Biological Chemistry.
[290] A. Tedgui,et al. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. , 2000, Circulation.
[291] J. Auwerx,et al. Down-regulation of hepatic lipase gene expression and activity by fenofibrate. , 1992, Biochimica et biophysica acta.
[292] K. Nakao,et al. Troglitazone induces GLUT4 translocation in L6 myotubes. , 2001, Diabetes.
[293] M. Lean,et al. Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. , 1999, Diabetes care.
[294] B. M. Forman,et al. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux , 2001, Nature Medicine.
[295] J. Pascussi,et al. Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[296] M. Jaye,et al. PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway , 2001, Nature Medicine.
[297] J. Hudson,et al. The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. , 2001, Pharmacogenetics.
[298] D. Moore,et al. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. , 1995, Molecular endocrinology.
[299] R. Hess,et al. NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RAT , 1965, Nature.
[300] P. Chambon,et al. TIF2, a 160 kDa transcriptional mediator for the ligand‐dependent activation function AF‐2 of nuclear receptors. , 1996, The EMBO journal.
[301] F. Ruschitzka,et al. Acute heart transplant rejection due to Saint John's wort , 2000, The Lancet.
[302] Jasmine Chen,et al. The orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolism. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[303] M. Nitta,et al. CPF: an orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7alpha-hydroxylase gene. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[304] A. Pfeiffer,et al. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. , 1998, The New England journal of medicine.
[305] R. Lawn,et al. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. , 2000, Biochemical and biophysical research communications.
[306] T. Sueyoshi,et al. The Nuclear Orphan Receptor CAR-Retinoid X Receptor Heterodimer Activates the Phenobarbital-Responsive Enhancer Module of the CYP2B Gene , 1998, Molecular and Cellular Biology.
[307] J. Auwerx,et al. p300 Interacts with the N- and C-terminal Part of PPARγ2 in a Ligand-independent and -dependent Manner, Respectively* , 1999, The Journal of Biological Chemistry.
[308] M. Makishima,et al. Human Bile Salt Export Pump Promoter Is Transactivated by the Farnesoid X Receptor/Bile Acid Receptor* , 2001, The Journal of Biological Chemistry.
[309] J. Olefsky,et al. Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects , 1992, Diabetes Care.
[310] K. Umesono,et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[311] S. Safe,et al. Reciprocal Activation of Xenobiotic Response Genes by Nuclear Receptors Sxr/pxr and Car , 2000 .
[312] Satoshi Tanaka,et al. PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance , 1999 .
[313] T. Buchanan,et al. Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes Mellitus , 1998, Annals of Internal Medicine.
[314] W. Wahli,et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. , 1997, Molecular endocrinology.
[315] J. Gustafsson,et al. OR-1, a member of the nuclear receptor superfamily that interacts with the 9-cis-retinoic acid receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[316] Kai Yu,et al. Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids (*) , 1995, The Journal of Biological Chemistry.
[317] J. Auwerx,et al. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. , 1995, The Journal of clinical investigation.
[318] S. H. Kim,et al. Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. , 2000, Diabetes.
[319] Margaret S. Wu,et al. Targeted Disruption of the Tumor Necrosis Factor-α Gene: Metabolic Consequences in Obese and Nonobese Mice , 1997, Diabetes.
[320] T. Willson,et al. Identification of a Bile Acid-responsive Element in the Human Ileal Bile Acid-binding Protein Gene , 1999, The Journal of Biological Chemistry.
[321] J. Auwerx,et al. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. , 1995, The Journal of clinical investigation.
[322] E. Kraegen,et al. The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat. , 1997, Metabolism: clinical and experimental.
[323] S. Noji,et al. Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells. , 1998, Biochemical and biophysical research communications.
[324] Y. Terauchi,et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.
[325] P. Meier,et al. Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver. , 1999, Gastroenterology.
[326] J. Hansen,et al. Peroxisome Proliferator-activated Receptor δ (PPARδ)-mediated Regulation of Preadipocyte Proliferation and Gene Expression Is Dependent on cAMP Signaling* , 2001, The Journal of Biological Chemistry.
[327] A. Tall,et al. Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. , 2000, The Journal of clinical investigation.
[328] R. Evans,et al. Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[329] M. You,et al. Alternative splicing of the K-ras gene in mouse tissues and cell lines. , 2001, Experimental lung research.
[330] E. Rubin,et al. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. , 1994, The Journal of clinical investigation.
[331] M. Matsuda,et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.
[332] R. Mukherjee,et al. The Human Peroxisome Proliferator-activated Receptor (PPAR) Subtype NUC1 Represses the Activation of hPPARα and Thyroid Hormone Receptors (*) , 1995, The Journal of Biological Chemistry.
[333] C. Fielding,et al. A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1. , 2000, Biochemistry.
[334] J. Lehmann,et al. Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs* , 1997, The Journal of Biological Chemistry.
[335] D. Lütjohann,et al. Cholesterol dynamics in the foetal and neonatal brain as reflected by circulatory levels of 24S‐hydroxycholesterol , 2001, Acta paediatrica.
[336] A. Mendez,et al. Membrane Lipid Domains Distinct from Cholesterol/Sphingomyelin-Rich Rafts Are Involved in the ABCA1-mediated Lipid Secretory Pathway* , 2001, The Journal of Biological Chemistry.
[337] T. Rea,et al. A novel compound that elevates high density lipoprotein and activates the peroxisome proliferator activated receptor. , 1998, Journal of lipid research.
[338] J. Auwerx,et al. Xol INXS: role of the liver X and the farnesol X receptors , 2001, Current opinion in lipidology.
[339] M. Makishima,et al. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. , 2001, Gastroenterology.
[340] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.
[341] N. Grishin,et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. , 2000, Science.
[342] C. M. Adams,et al. Interactions between Subunits of the Human Epithelial Sodium Channel* , 1997, The Journal of Biological Chemistry.
[343] T. Willson,et al. Adipose Tissue Resistin Expression Is Severely Suppressed in Obesity and Stimulated by Peroxisome Proliferator-activated Receptor γ Agonists* , 2001, The Journal of Biological Chemistry.
[344] S. Chua,et al. Obesity and diabetes in TNF-alpha receptor- deficient mice. , 1998, The Journal of clinical investigation.
[345] S. Ekins,et al. The role of CYP2B6 in human xenobiotic metabolism. , 1999, Drug metabolism reviews.
[346] Jean-Marc A. Lobaccaro,et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ , 2000 .
[347] D. Mangelsdorf,et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. , 2000, Science.
[348] K. Uysal,et al. Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.
[349] T. Ishihara,et al. Actions of novel antidiabetic thiazolidinedione, T‐174, in animal models of non‐insulin‐dependent diabetes mellitus (NIDDM) and in cultured muscle cells , 1998, British journal of pharmacology.
[350] L. Moore,et al. Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. , 2001, Molecular pharmacology.
[351] C. Glass,et al. The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.
[352] K. Griffin,et al. Identification of Peroxisome Proliferator-responsive Human Genes by Elevated Expression of the Peroxisome Proliferator-activated Receptor α in HepG2 Cells* , 2001, The Journal of Biological Chemistry.
[353] L. Moore,et al. The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution , 2000 .
[354] P. Portincasa,et al. Effects of bile salt hydrophobicity on crystallization of cholesterol in model bile , 1996, European journal of clinical investigation.
[355] M. Rao,et al. Isolation and Characterization of Peroxisome Proliferator-activated Receptor (PPAR) Interacting Protein (PRIP) as a Coactivator for PPAR* , 2000, The Journal of Biological Chemistry.
[356] Aldons J. Lusis,et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[357] R. Evans,et al. The RXR heterodimers and orphan receptors , 1995, Cell.
[358] D. Mangelsdorf,et al. Role of LXRs in control of lipogenesis. , 2000, Genes & development.
[359] M. Otsuki,et al. Troglitazone Stimulates Pancreatic Growth in Normal Rats , 2002, Pancreas.
[360] C. Paulusma,et al. The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man , 1997, Journal of Molecular Medicine.
[361] J. Piette,et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.
[362] R. F. Hoyt,et al. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[363] A. Walsh,et al. Dietary Cholesterol Fails to Stimulate the Human Cholesterol 7α-Hydroxylase Gene (CYP7A1) in Transgenic Mice* 210 , 2002, The Journal of Biological Chemistry.
[364] T. Willson,et al. Liver X Receptor (LXR) Regulation of the LXRα Gene in Human Macrophages* , 2001, The Journal of Biological Chemistry.
[365] B. Spiegelman,et al. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. , 1994, Endocrinology.
[366] N. Tajima,et al. Effect of troglitazone on body fat distribution in type 2 diabetic patients. , 1999, Diabetes care.
[367] J. Auwerx,et al. PPARgamma activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes. , 1998, Atherosclerosis.
[368] B. Cohen,et al. Modulation of Insulin Activities by Leptin , 1996, Science.
[369] A. Tall,et al. ATP-binding Cassette Transporter A1 (ABCA1) Functions as a Cholesterol Efflux Regulatory Protein* , 2001, The Journal of Biological Chemistry.
[370] P. Scherer,et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.
[371] P. Puigserver,et al. A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis , 1998, Cell.
[372] M. Rao,et al. Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor gamma. , 1996, Gene expression.
[373] T. Langmann,et al. Native LDL Upregulation of ATP‐Binding Cassette Transporter‐1 in Human Vascular Endothelial Cells , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[374] B. Neuschwander‐Tetri,et al. Humanized xenobiotic response in mice expressing nuclear receptor SXR , 2000, Nature.
[375] M. Daly,et al. Guilt by association , 2000, Nature Genetics.
[376] G. Cooney,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Expression of Genes Involved in Lipid Metabolism Correlate with Peroxisome Proliferator-Activated Receptor � Expression in Human Skeletal Muscle , 2000 .
[377] G. Schmitz,et al. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[378] Jatinder Lamba,et al. Disrupted Bile Acid Homeostasis Reveals an Unexpected Interaction among Nuclear Hormone Receptors, Transporters, and Cytochrome P450* , 2001, The Journal of Biological Chemistry.
[379] M. Eriksson,et al. Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans. , 1999, Circulation.
[380] R. Hiipakka,et al. Selective activation of liver X receptor alpha by 6α-hydroxy bile acids and analogs , 2000, Steroids.
[381] J. Lehmann,et al. Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.
[382] A. Itai,et al. Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. , 2001, The Journal of clinical investigation.
[383] Barry M. Forman,et al. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ , 1997 .
[384] K. M. Popov,et al. Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects. , 1998, Molecular genetics and metabolism.
[385] B. Spiegelman,et al. An adipogenic cofactor bound by the differentiation domain of PPARγ , 1999, The EMBO journal.
[386] Shelagh Wilson,et al. Interactions Between Leptin and Hypothalamic Neuropeptide Y Neurons in the Control of Food Intake and Energy Homeostasis in the Rat , 1997, Diabetes.
[387] T. Funahashi,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .
[388] J. Auwerx,et al. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. , 1994, The Journal of biological chemistry.
[389] Y. Kong,et al. Cloning and Characterization of a Novel Human Hepatocyte Transcription Factor, hB1F, Which Binds and Activates Enhancer II of Hepatitis B Virus* , 1998, The Journal of Biological Chemistry.
[390] P. Edwards,et al. Identification of the DNA Binding Specificity and Potential Target Genes for the Farnesoid X-activated Receptor* , 2000, The Journal of Biological Chemistry.
[391] B. Topp,et al. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. , 2001, Diabetes.
[392] Margaret S. Wu,et al. Novel Peroxisome Proliferator-activated Receptor (PPAR) γ and PPARδ Ligands Produce Distinct Biological Effects* , 1999, The Journal of Biological Chemistry.
[393] T. Kawamoto,et al. Phenobarbital-Responsive Nuclear Translocation of the Receptor CAR in Induction of the CYP2B Gene , 1999, Molecular and Cellular Biology.
[394] J. H. Johnson,et al. Thiazolidinediones and insulin resistance: peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[395] M. Matsuda,et al. Small Heterodimer Partner, an Orphan Nuclear Receptor, Augments Peroxisome Proliferator-activated Receptor γ Transactivation* , 2002, The Journal of Biological Chemistry.
[396] D. Mangelsdorf,et al. An oxysterol signalling pathway mediated by the nuclear receptor LXRα , 1996, Nature.
[397] C. Klaassen,et al. Induction of rat organic anion transporting polypeptide 2 by pregnenolone-16alpha-carbonitrile is via interaction with pregnane X receptor. , 2002, Molecular pharmacology.
[398] J. Breslow,et al. Sequence and expression of Tangier apoA-I gene. , 1988, European journal of biochemistry.
[399] R. Morrison,et al. Hormonal signaling and transcriptional control of adipocyte differentiation. , 2000, The Journal of nutrition.